BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28794252)

  • 1. White matter hyperintensity reduction and outcomes after minor stroke.
    Wardlaw JM; Chappell FM; Valdés Hernández MDC; Makin SDJ; Staals J; Shuler K; Thrippleton MJ; Armitage PA; Muñoz-Maniega S; Heye AK; Sakka E; Dennis MS
    Neurology; 2017 Sep; 89(10):1003-1010. PubMed ID: 28794252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White Matter Hyperintensity Volume Influences Symptoms in Patients Presenting With Minor Neurological Deficits.
    Zerna C; Yu AYX; Hong ZM; Penn AM; Lesperance ML; Croteau NS; Balshaw RF; Votova K; Bibok MB; Saly V; Modi J; Hegedus J; Klourfeld E; Coutts SB;
    Stroke; 2020 Feb; 51(2):409-415. PubMed ID: 31795896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal white matter hyperintensity changes and cognitive decline in patients with minor stroke.
    Jiang J; Yao K; Huang X; Zhang Y; Shen F; Weng S
    Aging Clin Exp Res; 2022 May; 34(5):1047-1054. PubMed ID: 35084664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Small Vessel Disease Progression on Long-term Cognitive and Functional Changes After Stroke.
    Clancy U; Makin SDJ; McHutchison CA; Cvoro V; Chappell FM; Hernández MDCV; Sakka E; Doubal F; Wardlaw JM
    Neurology; 2022 Apr; 98(14):e1459-e1469. PubMed ID: 35131905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White Matter Hyperintensity, Immediate Antihypertensive Treatment, and Functional Outcome After Acute Ischemic Stroke.
    Zhu S; Qian S; Xu T; Peng H; Dong R; Wang D; Yuan X; Guo L; Zhang Y; Geng D; Zhong C
    Stroke; 2020 May; 51(5):1608-1612. PubMed ID: 32233741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired renal function is associated with brain atrophy and poststroke cognitive decline.
    Auriel E; Kliper E; Shenhar-Tsarfaty S; Molad J; Berliner S; Shapira I; Ben-Bashat D; Shopin L; Tene O; Rosenberg GA; Bornstein NM; Ben Assayag E
    Neurology; 2016 May; 86(21):1996-2005. PubMed ID: 27164678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study.
    Chappell FM; Del Carmen Valdés Hernández M; Makin SD; Shuler K; Sakka E; Dennis MS; Armitage PA; Muñoz Maniega S; Wardlaw JM
    Trials; 2017 Feb; 18(1):78. PubMed ID: 28222778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging.
    Scharf EL; Graff-Radford J; Przybelski SA; Lesnick TG; Mielke MM; Knopman DS; Preboske GM; Schwarz CG; Senjem ML; Gunter JL; Machulda M; Kantarci K; Petersen RC; Jack CR; Vemuri P
    Stroke; 2019 Nov; 50(11):3037-3044. PubMed ID: 31510903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal-appearing white matter microstructural injury is associated with white matter hyperintensity burden in acute ischemic stroke.
    Etherton MR; Wu O; Giese AK; Rost NS
    Int J Stroke; 2021 Feb; 16(2):184-191. PubMed ID: 31847795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal-Appearing White Matter Integrity Is a Predictor of Outcome After Ischemic Stroke.
    Sagnier S; Catheline G; Dilharreguy B; Linck PA; Coupé P; Munsch F; Bigourdan A; Debruxelles S; Poli M; Olindo S; Renou P; Rouanet F; Dousset V; Berthoz S; Tourdias T; Sibon I
    Stroke; 2020 Feb; 51(2):449-456. PubMed ID: 31906830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White Matter Integrity and Early Outcomes After Acute Ischemic Stroke.
    Etherton MR; Wu O; Giese AK; Lauer A; Boulouis G; Mills B; Cloonan L; Donahue KL; Copen W; Schaefer P; Rost NS
    Transl Stroke Res; 2019 Dec; 10(6):630-638. PubMed ID: 30693424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter hyperintensity quantification in large-scale clinical acute ischemic stroke cohorts - The MRI-GENIE study.
    Schirmer MD; Dalca AV; Sridharan R; Giese AK; Donahue KL; Nardin MJ; Mocking SJT; McIntosh EC; Frid P; Wasselius J; Cole JW; Holmegaard L; Jern C; Jimenez-Conde J; Lemmens R; Lindgren AG; Meschia JF; Roquer J; Rundek T; Sacco RL; Schmidt R; Sharma P; Slowik A; Thijs V; Woo D; Vagal A; Xu H; Kittner SJ; McArdle PF; Mitchell BD; Rosand J; Worrall BB; Wu O; Golland P; Rost NS;
    Neuroimage Clin; 2019; 23():101884. PubMed ID: 31200151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White Matter Hyperintensity-Adjusted Critical Infarct Thresholds to Predict a Favorable 90-Day Outcome.
    Patti J; Helenius J; Puri AS; Henninger N
    Stroke; 2016 Oct; 47(10):2526-33. PubMed ID: 27633020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term progression of white matter hyperintensities in ischemic stroke.
    Holmegaard L; Jensen C; Redfors P; Blomstrand C; Jern C; Jood K
    Acta Neurol Scand; 2018 Dec; 138(6):548-556. PubMed ID: 30152523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-dependent association of white matter abnormality with cognition after TIA or minor stroke.
    Zamboni G; Griffanti L; Mazzucco S; Pendlebury ST; Rothwell PM
    Neurology; 2019 Jul; 93(3):e272-e282. PubMed ID: 31201296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter hyperintensity load on stroke recurrence and mortality at 1 year after ischemic stroke.
    Ryu WS; Schellingerhout D; Hong KS; Jeong SW; Jang MU; Park MS; Choi KH; Kim JT; Kim BJ; Lee J; Cha JK; Kim DH; Nah HW; Lee SJ; Kim JG; Cho YJ; Lee BC; Yu KH; Oh MS; Park JM; Kang K; Lee KB; Park TH; Park SS; Lee J; Bae HJ; Kim DE
    Neurology; 2019 Aug; 93(6):e578-e589. PubMed ID: 31308151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrity of normal-appearing white matter and functional outcomes after acute ischemic stroke.
    Etherton MR; Wu O; Cougo P; Giese AK; Cloonan L; Fitzpatrick KM; Kanakis AS; Boulouis G; Karadeli HH; Lauer A; Rosand J; Furie KL; Rost NS
    Neurology; 2017 May; 88(18):1701-1708. PubMed ID: 28381507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of White Matter Hyperintensity Markers on MRI and Long-term Risk of Mortality and Ischemic Stroke: The SMART-MR Study.
    Ghaznawi R; Geerlings MI; Jaarsma-Coes M; Hendrikse J; de Bresser J;
    Neurology; 2021 Apr; 96(17):e2172-e2183. PubMed ID: 33727406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Regional White Matter Hyperintensities With Longitudinal Alzheimer-Like Pattern of Neurodegeneration in Older Adults.
    Rizvi B; Lao PJ; Chesebro AG; Dworkin JD; Amarante E; Beato JM; Gutierrez J; Zahodne LB; Schupf N; Manly JJ; Mayeux R; Brickman AM
    JAMA Netw Open; 2021 Oct; 4(10):e2125166. PubMed ID: 34609497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White Matter Hyperintensity Volume and Outcome of Mechanical Thrombectomy With Stentriever in Acute Ischemic Stroke.
    Atchaneeyasakul K; Leslie-Mazwi T; Donahue K; Giese AK; Rost NS
    Stroke; 2017 Oct; 48(10):2892-2894. PubMed ID: 28887393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.